• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations?
  Somenath Panda,Kaushik Kundu,Anusha Basaiahgari,Sanjib Senapati,Ramesh L. Gardas New J. Chem., 2018,42, 7105-7118
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

Comprehensive Overview of 1-Allyl-3-methyl-1H-pyrazole-4-carbaldehyde (CAS No. 899709-47-8): Properties, Applications, and Innovations

1-Allyl-3-methyl-1H-pyrazole-4-carbaldehyde (CAS No. 899709-47-8) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique pyrazole core structure and reactive aldehyde functional group. This compound belongs to the heterocyclic aldehyde family, which is widely explored for its versatility in synthesizing bioactive molecules. Its molecular formula, C₈H₁₀N₂O, and precise structural features make it a valuable intermediate in modern organic synthesis.

Recent trends in drug discovery and green chemistry have amplified interest in 1-Allyl-3-methyl-1H-pyrazole-4-carbaldehyde. Researchers are investigating its potential as a building block for antimicrobial agents and enzyme inhibitors, aligning with the global demand for novel therapeutics. The compound's allyl group offers additional reactivity for cross-coupling reactions, a hotspot in catalytic chemistry. Meanwhile, its carbaldehyde moiety enables condensation reactions, critical for constructing N-heterocyclic scaffolds prevalent in FDA-approved drugs.

From an industrial perspective, 899709-47-8 is often discussed in forums focusing on high-value chemical intermediates. Its synthesis typically involves Vilsmeier-Haack formylation of pyrazole derivatives, a process optimized for scalability and yield. Environmental concerns have also driven innovations in its production, with studies exploring solvent-free methodologies and biocatalytic routes to reduce waste. These advancements address the growing emphasis on Sustainable Chemistry in the Fine Chemicals sector.

Analytical characterization of 1-Allyl-3-methyl-1H-pyrazole-4-carbaldehyde relies on advanced techniques like HPLC-MS and NMR spectroscopy, ensuring purity for sensitive applications. Stability studies indicate optimal storage under inert conditions, reflecting standard practices for air-sensitive aldehydes. The compound's logP value and hydrogen-bonding capacity further make it a subject in computational chemistry models predicting drug-likeness.

Emerging applications include its use in material science, particularly for designing photoactive polymers and coordination complexes with transition metals. Such developments resonate with the Internet of Things (IoT) era, where functional materials are crucial for sensors and smart devices. Patent analyses reveal increasing filings involving this compound, especially in Asia-Pacific markets, highlighting its commercial potential.

For researchers sourcing CAS 899709-47-8, quality parameters like ≥98% purity and residual solvent levels are critical considerations. Reputable suppliers provide COA (Certificate of Analysis) documentation, aligning with Good Laboratory Practice (GLP) standards. The compound's pricing reflects its niche status, with bulk availability becoming more common as demand grows in contract research organizations (CROs).

Future directions may explore 1-Allyl-3-methyl-1H-pyrazole-4-carbaldehyde's role in click chemistry and PROTAC (Proteolysis Targeting Chimera) technologies, two rapidly evolving fields in targeted drug delivery. Its structural flexibility could also contribute to covalent inhibitor design, addressing challenges in oncology research. These prospects position the compound as a noteworthy candidate in the next decade of medicinal chemistry breakthroughs.

• 113131-46-7(1-ethyl-3-methyl-pyrazole-4-carboxylic acid)
• 113100-63-3(1H-Pyrazole-4-carbonylchloride, 3-methyl-1-(2-propen-1-yl)-)
• 1015846-06-6(1-Allyl-3,5-dimethyl-1H-pyrazole-4-carboxylic acid)
• 1155595-91-7(3,5-dimethyl-1-(prop-2-en-1-yl)-1H-pyrazole-4-carbaldehyde)
• 933778-29-1(1-Ethyl-5-methyl-1H-pyrazole-4-carbaldehyde)
• 676348-38-2(1-Ethyl-3-methyl-1H-pyrazole-4-carbaldehyde)
• 933778-28-0(3-Methyl-1-propyl-1H-pyrazole-4-carbaldehyde)
• 701911-46-8(1-Ethyl-3,5-dimethyl-1H-pyrazole-4-carbaldehyde)
• 957313-16-5(1-Allyl-5-methyl-1H-pyrazole-4-carbaldehyde)
• 946658-56-6(1-(1-Ethyl-3-methyl-1H-pyrazol-4-yl)ethanone)